TCRX

TSCAN THERAPEUTICS INC

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

TSCAN THERAPEUTICS INC (TCRX) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$6.16M; the largest are Baker Bros. Advisors, Renaissance Technologies, Izzy Englander. This quarter: 1 added, 2 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · MediumThis quarter · Quiet

Common-stock holders4

Congress trades0

Price$0.32vs quarter-end-67.61%

Sectors0

This quarter's moves

New0

Added1

Trimmed / sold2

Top holderBaker Bros. Advisors

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Baker Bros. AdvisorsHold

Value $2.73M0.0% of portfolio2,784,7922026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Baker Bros. Advisors	2026 Q2	$2.73M	2,784,792	0.0%	Hold

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.